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The T cell receptor (TCR) interacts with peptide-major histocompatibility complex (pMHC)
to enable T cell development and trigger adaptive immune responses. For this reason,
TCR:pMHC interactions have been intensely studied for over two decades. However, the
details of how various binding parameters impact T cell activation remain elusive. Most
measurements were made using recombinant proteins by surface plasmon resonance, a
three-dimensional (3D) technique in which ﬂuid-phase receptors and ligands are removed
from their cellular environment.This approach foundTCR:pMHC interactions with relatively
low afﬁnities and slow off-rates for agonist peptides. Newer generation techniques have
analyzed TCR:pMHC interactions in two dimensions (2D), with both proteins anchored
in apposing plasma membranes. These approaches reveal in situ TCR:pMHC interaction
kinetics that are of high afﬁnity and exhibit rapid on- and off-rates upon interaction with
agonist ligands. Importantly, 2D binding parameters correlate better with T cell functional
responses to a spectrum of ligands than 3D measures.
Keywords: kinetics, affinity, molecular interaction, 2D binding,T cell activation
INTRODUCTION
T cell activation is a critical aspect of the development of effective
immunity to a variety of pathogens, as well as a key component
governing the development of T cell mediated autoimmune dis-
eases. A number of parameters control the outcome of a T cell’s
interaction with an antigen presenting cell (APC). These include:
(1) The afﬁnity and kinetics of the T cell receptor interaction with
the peptide:MHC complex; (2) The stability of the peptide:MHC
interaction; (3) Signaling events within the T cell downstream of
the TCR, various costimulatory pathways and cytokine receptors.
By altering any of these events, we can modulate the outcome of
the T cell:APC interaction to improve or impair the resulting T
cell function.
The binding afﬁnity and kinetics of the T cell receptor interac-
tion with the peptide:MHC complex are thought to be the earliest
parameters governing T cell activation. Most of these parameters
have been obtained using surface plasmon resonance (SPR) or
pMHC tetramer technologies, which measure interaction in three
dimensions (3D)withoneof the interactingmolecules in theﬂuid-
phase and being removed from their cellular environment (Corr
et al., 1994; Matsui et al., 1994; Holmberg et al., 2003; Krogs-
gaard et al., 2003). The results portrayed TCR:pMHC binding as
a low afﬁnity (K d∼ 1–100μM) and slow dissociation (half-life
∼ tens of seconds for agonist peptides) interaction (Corr et al.,
1994; Matsui et al., 1994; Krogsgaard et al., 2003). SPR data of
TCR:pMHC interaction for different T cell model systems and
panels of different peptides strongly supported the idea that the
duration of this interaction is a key factor that determines T cell
signaling strength (Matsui et al., 1994; Davis et al., 1998; Germain
and Stefanova, 1999; van der Merwe, 2001). Strongly activating
ligands showed the longer interaction lifetimes, leading to a theo-
retical framework termed the kinetic proofreading model, which
suggests that this duration should be sufﬁciently long to allow ini-
tiation and completion of multiple steps of the signaling cascade,
thus resulting in full T cell activation (McKeithan, 1995). However,
many“outliers”were observed (van derMerwe, 2001; Rudolph and
Wilson, 2002). In particular, rarely was a clear correlation observed
between kinetic measurements and T cell function for antagonist
ligands (Alam et al., 1996; Rosette et al., 2001).
More recently, new methods have been developed and utilized
to enable in situ measurements of binding kinetics and afﬁnity of
surface T cell receptors interacting across the junctional space with
ligands anchored in apposing membrane, i.e., two-dimensional
(2D) binding (Huang et al., 2007, 2010; Huppa et al., 2010; Jiang
et al., 2011). Although we are beginning to understand the impact
that various kinetic parameters can have on the initiation of T
cell activation (Huang et al., 2010; Huppa et al., 2010; Jiang et al.,
2011),how these interactions are translated into a functional signal
within the T cell remains an area of intense investigation. In this
review, we discuss the 2D techniques for analyzing TCR:pMHC
interaction kinetics, how these measurements differ from their 3D
counterparts, what impact various kinetic parameters can have
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on the initiation of T cell activation, and the limitations of pMHC
tetramer staining as a means of identifying antigen reactive T cells.
SUMMARY OF EXISTING TWO DIMENSIONAL TECHNIQUES
In SPR, the binding kinetic parameters (on-rate, off-rate propor-
tional to reciprocal half-life, and afﬁnity as the ratio of on- and
off-rates) are measured with one interacting partner immobilized
on a solid support and the other interacting partner suspended
in the ﬂuid phase. This approach reveals properties of the funda-
mental physical chemistry of the puriﬁed molecules without any
potential inﬂuence of the respective cell surfaces, hence considered
as“intrinsic”kinetic parameters. The kinetic parametersmeasured
by SPR have been thought to accurately describe interactions of
the same molecules during cell–cell interactions. This assumption
is sometimes valid, but rarely tested, and often taken for granted.
The 3D approach to analyzing the interactions of the TCR
and pMHC with both interacting partners being puriﬁed pro-
teins has a weakness in that these studies cannot faithfully repli-
cate many unique aspects of membrane-anchored proteins. To
circumvent this problem and thus more accurately study the
interactions that occur in vivo, systems have been developed to
study these interactions in two dimensions, i.e., with both proteins
anchored in a membrane and the interaction occurring across the
intercellular junction. These include two ﬂuorescent-based assays
(Tolentino et al., 2008;Wu et al., 2008; Huppa et al., 2010) and two
mechanical-based assays (Chesla et al., 1998; Chen et al., 2008).
One of the ﬂuorescent-based assays employs the technique of ﬂuo-
rescence recovery after photobleaching (FRAP) within the contact
area between a receptor-expressing cell and a ligand reconstituted
lipid bilayer, which analyzes binding of a population of a large
number of interacting molecules (Tolentino et al., 2008; Wu et al.,
2008). The other ﬂuorescent-based assay employs the technique of
Förster resonance energy transfer (FRET), which analyzes dissoci-
ation of a single receptor:ligand bond (Huppa et al., 2010). Both
the mechanical-based assays use red blood cells (RBCs) as a force
sensor to detect binding (Chesla et al., 1998; Chen et al., 2008).
Here we focus on the recent application of these techniques to
study the interactions of TCR, co-receptors (CD4 and CD8), and
pMHC (Huang et al., 2007, 2010; Zarnitsyna et al., 2007; Wasser-
man et al., 2008; Huppa et al., 2010; Jiang et al., 2011; Sabatino
et al., 2011).
In the FRET-based assay (Huppa et al., 2010), T cells were
stained with a ﬂuorescently labeled anti-TCR monoclonal anti-
body Fab directed against an epitope close to the pMHC binding
site, which serves as either the FRET donor or acceptor. The other
FRET partner is a ﬂuorescently labeled peptide complexed with
an MHC molecule. The lipid-anchored pMHC is reconstituted
into a glass-supported lipid bilayer along with non-ﬂuorescent
intercellular adhesion molecule 1 (ICAM-1) and B7-1 (CD80).
Upon addition of the T cell to this planar membrane, formation
of microclusters and immunological synapse mediated by interac-
tions between TCR and pMHC, lymphocyte function-associated
antigen 1 (LFA-1) and ICAM-1, and CD28 and B7-1 occurs, and
the TCR:pMHC interaction can be visualized by the ﬂuorescent
signal generated when the FRET donor excites the acceptor. The
2D K d values for this interaction are obtained by measuring the
FRETyield of entire synapses orTCRmicroclusters inside synapses
using FRET donor recovery after FRET acceptor photobleaching.
Lifetimes of individual TCR:pMHC bonds are measured using
single-molecule FRET microscopy from which the corresponding
off-rates of dissociation are derived.
In the micropipette adhesion frequency assay (Chesla et al.,
1998), an RBC serves as both a surrogate APC as well as an adhe-
sion sensor. The APC is prepared by coating pMHC onto the RBC
membrane through biotin–streptavidin coupling. The adhesion
sensor is formed by pressurizing the RBC with micropipette aspi-
ration. An intact T cell is brought into contact with an RBC by
motorized micromanipulation to enable TCR:pMHC interaction
within the ﬁrst few seconds before any microcluster or immuno-
logical synapse formation processes are observed. Unlike other
assays that measure various physical attributes of cell adhesion,
such as its mechanical strength or force, this assay measures the
likelihood of occurrence of the interaction between the TCR and
pMHC. This likelihood is estimated from the frequency of adhe-
sion events visualized by elongation of the RBCmembrane, should
adhesion be present at the end of a deﬁned contact time when the
T cell is retracted from the RBC. The molecular bond forma-
tion and dissociation kinetics are evaluated from the measured
adhesion frequency as a function of contact time. From known
site densities of a bimolecular interaction, the 2D receptor:ligand
afﬁnity is evaluated from the steady-state adhesion frequency and
the off-rate is evaluated from the contact time required for the
adhesion frequency to reach half of the steady-state level (Chesla
et al., 1998).
In a “high-tech”version of the micropipette system, pMHC lig-
ands are coated on the surface of a small glass bead attached to a
RBC to form a biomembrane force probe (BFP) to allow tracking
of its position precisely and rapidly (Evans et al., 1995). When it is
used toperform the adhesion frequency assay, theBFPcanmeasure
receptor:ligand dissociation far more rapidly than 5 s−1, the fastest
off-rate reliably measurable by the“low-tech”micropipette system
(Huang et al., 2010). With substantially increased resolutions for
time (sub-milliseconds), displacement (a few nanometers), and
force (single pico-newton), the BFP can be used to perform the
thermal ﬂuctuation assay, which is more reliable for measuring
off-rates of rapid receptor:ligand dissociation (Chen et al., 2008).
Unlike the adhesion frequency assay that detects the presence of
bond(s) at the end of a given contact duration, the thermal ﬂuctu-
ation assay identiﬁes individual bond formation and dissociation
events during a contact period by monitoring changes in the ther-
mal ﬂuctuations of the BFP sensor. The off-rate is determined
from the statistics of bond lifetimes measured from the moment
of bond formation to the moment of bond dissociation (Chen
et al., 2008).
DIFFERENCES BETWEEN 2D AND 3D MEASUREMENTS AND
THEIR CORRELATIONS WITH T CELL FUNCTION
Upon binding to TCR, different peptides can elicit a wide range of
functional responses, and it is generally hypothesized that bio-
physical parameters of binding kinetics including afﬁnity and
half-life determine the downstream signaling events. This hypoth-
esis had previously been tested with measurements in which one
of the interacting molecules was in solution (3D assay with SPR).
A major recent advance has been that two papers published in
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2010 tested this hypothesis with in situ measurements in which
both TCR and pMHC are on the corresponding cell surfaces, one
using ﬂuorescent-based (Huppa et al., 2010) and the other using
mechanical-based (Huang et al., 2010) 2D assays. Here we will
compare 2D and 3D measurements. While data obtained with
ﬂuorescent-based assays are also discussed, majority of the com-
parisons are made using data obtained with our mechanical-based
assays. An example is depicted in Figure 1 and tabulated in Table 1
using the system of the OT1 TCR interacting with a panel of class I
pMHC (H2-Kb) ligands that exhibit six orders of magnitude vari-
ations in functional responses, as measured, for example, by the
peptide concentration required to stimulate half-maximum level
of T cell proliferation (Huang et al., 2010).
The 2D TCR:pMHC on-rates for the OT1 system span a
broad 4-log range that correlate well with the peptide potencies
(Figure 1A). In sharp contrast, the corresponding 3D on-rates
are compressed into a narrow range of merely ﬁvefold differences
around ∼103 M−1s−1, exhibiting no correlation with the 2D on-
rates (Figure 1A) and downstream T cell functions (Alam et al.,
1996; Rosette et al., 2001). The 2D and 3D off-rates have com-
parable but small dynamic ranges for the same pMHC panel, but
surprisingly, the former are orders of magnitude faster than the lat-
ter (Figure 1B). Even more unexpectedly, they correlate negatively
to each other. The 2D and 3D afﬁnities show good correlation
(Figure 1C), at least for this system. Due to the insensitivity of
3D on-rates to peptide potencies, the negative correlation of T
cell responsiveness with 3D off-rates translates to a positive cor-
relation with 3D afﬁnities (Figure 1C). Although the 2D off-rates
correlate positively with peptide potencies, their 1-log range is
compensated by the 4-log range of the 2D on-rates that also corre-
late positively with peptide potencies. As a result, the 2D afﬁnities,
which equal the ratios of 2D on- and off-rates, show a broad 3-log
dynamic range and positive correlation with the T cell responsive-
ness (Figure 1C). Fast dissociation from their respective agonist
ligands was also observed for the F5 (Jiang et al., 2011) and 42F3
(Adams et al., 2011) TCR systems.
Similar observations have also been made using a ﬂuorescent-
based assay. 2D binding data of two TCRs, 2B4 and 5c.c7, for a
moth cytochrome c peptide presented by the class II MHC (I-Ek)
were generatedby single-molecule FRETexperiment (Huppa et al.,
2010). The off-rates of TCR–pMHC complexes are 4- to 12-fold
higher than SPR measurements and the TCR afﬁnity for cognate
FIGURE 1 | Comparison between 2D and 3D kinetic parameters. (A–C)
Effective 2D on-rates (A), off-rates (B) and effective 2D afﬁnities (C) are
respectively plotted versus 3D on-rates, off-rates, and afﬁnities for
bimolecular interactions between the OT1TCR and a panel of pMHC
ligands at room (25˚C, closed symbols) and body (37˚C, open symbols)
temperatures. The 3D data are measured by SPR (Alam et al., 1999;
Rosette et al., 2001) and the 2D data are measured by the micropipette
adhesion frequency assay and the BFP thermal ﬂuctuation assay (Huang
et al., 2010). Different peptides in (A–C) are indicated with different
symbols (∗∗ - OVA, • ◦ - A2, xx - G4,  - V-OVA,  - E1, ♦ - R4). (D)
Normalized adhesion bonds at equilibrium, calculated by converting the
steady-state adhesion frequency P a to the average number of bonds,
−ln(1−P a), normalized by pMHC density, mpMHC, of TCR:pMHC (red
circles) and pMHC:CD8 (blue circles) bimolecular interactions as well as
TCR:pMHC:CD8 (black circles) trimolecular interactions are plotted versus
3D afﬁnities of the correspondingTCR:pMHC and pMHC:CD8 bimolecular
interactions. The 3D afﬁnities for TCR:pMHC are the same as those in
panel C and that for pMHC:CD8 interaction is from (Leishman et al., 2001).
The 2D normalized bond values are from (Jiang et al., 2011). The
corresponding peptides in the pMHC complexes are indicated.
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peptide was elevated, together with an increase in association rate
(Huppa et al., 2010).
Direct comparisons of on-rates and afﬁnities obtainedusing 2D
and3Dmethods are not possible because the interactingmolecules
reside in spaces of different dimensions. Thus, their concentra-
tions use different units: number of molecules per area in 2D and
Table 1 | Comparison between 2D and 3D parameters forTCR–pMHC
interaction (cf. Figure 1).
2D 3D
Afﬁnity range Broad (3 logs) Narrow (1 log)
Afﬁnity strength Strong for agonist Weak interaction
On-rate range Broad (4 logs) Narrow (<1 log)
On-rate Very fast for agonist Slow association
Off-rate Very fast Intermediate
Correlation with
functional data
Strong correlations with
afﬁnity and on-rate, weak
correlation with off-rate
Weak correlation with
afﬁnity, inverse correla-
tion with off-rate
per volume in 3D. As such, the on-rate and afﬁnity have distinct
units in 2D and 3D, and thus cannot be directly compared. By
comparison, off-rate has the same unit of reciprocal time in both
dimensions. For this reason, it has been suggested that off-rates
should have the same values regardless of the dimension (Dustin
et al., 2001), which is indeed the case for PSGL-1 dissociation from
P- and L-selectins (Mehta et al., 1998; Chen et al., 2008; Klopocki
et al., 2008). Surprisingly, the 2D off-rates for TCR:pMHC inter-
actions are orders of magnitude faster than their 3D counterparts
(Figure 1B; Huang et al., 2010). The OT1 TCR dissociates from
OVA:H2-Kb with an off-rate of 10.8 s−1 at 37˚C, equivalent to
that of L-selectin dissociating from PSGL-1 (10.2 s−1 at room
temperature; Chen et al., 2008), the most rapid selectin:ligand off-
rate required for mediating fast rolling of leukocytes on vascular
surfaces. Although the fast 2D off-rate of the L-selectin:PSGL-1
bond corresponds to its fast 3D off-rate (Klopocki et al., 2008),
those of the 2D TCR:pMHC bonds do not match the 3D values
(Figure 1B).
It is interesting to note that the substantial differences between
2D and 3D kinetics of TCR:pMHC interactions are not seen in lig-
and binding of selectins and integrins. 2D afﬁnity for the agonist
FIGURE 2 | Formation ofTCR:pMHC:CD8 trimolecular complex.
(A) Resting state with no interaction betweenTCR, CD8, and pMHC.
(B) Binding of TCR with MHC complexed with agonist peptide (closed
symbol) as a ﬁrst step of the trimolecular interaction. (C)Weak
interaction between CD8 and MHC bearing self-peptide (open
symbol). (D) Assembly of TCR:pMHC:CD8 trimolecular functional
complex. Lck molecules are shown in two states – free-state and
bound to CD8 – and in two conformations. Dotted arrows indicate an
involvement of actin cytoskeleton duringT cells activation (Burkhardt
et al., 2008).
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peptide is comparable with 2D afﬁnity measured for integrin
αLβ2 at a high afﬁnity state interacting with ICAM-1 (Zhang
et al., 2005). It was generally accepted based on SPR data that
the TCR:pMHC interaction is of relatively low afﬁnity, but 2D
data argues against this paradigm, demonstrating a broad range
of afﬁnities which correlates well with the peptide potency for
both OT1 and 42F3 TCR systems (Huang et al., 2010; Adams
et al., 2011). As antigenic peptides are usually rare on the APC
surface, one of the mechanisms to optimally utilize this high ago-
nist binding capacity is the formation of “protein islands” with
clusters of TCRs that will allow effective scanning of APC sur-
face (Huppa et al., 2010). For this mechanism to work, however,
it requires that the signaling cascade have memory, i.e., not be
interrupted by brief disengagements of the TCR:pMHC bond.
It also requires that the downstream processes integrate signals
from different TCRs triggered by the same pMHC in a relay fash-
ion. Interestingly, sequential brief contacts between a T cell and
an APC in micropipette adhesion frequency assay usually pro-
duce consecutive adhesion events with interlude of consecutive
no-adhesion events (Zarnitsyna et al., 2007). The “memory effect”
(i.e., TCR:pMHC interaction is more likely to occur after a contact
that results in an interaction than a contact that yields no interac-
tion, as if it remembers what just happened in the past) discovered
from analyzing such “adhesion event clusters” is consistent with
the aforementioned memory requirement. The clusters of sequen-
tial adhesion events might reﬂect probing of agonist pMHC by
pre-formed TCR clusters.
How do we explain this drastic difference between SPR and
2D micropipette measurements? In light of the recent reports
of TCR clustering on the cell surface in a cholesterol- and actin
cytoskeleton-dependent fashion, we can speculate that the T cell
may exhibit unique regulation of TCR organization, orientation,
and/or conformation that may affect the availability of TCR to
pMHC binding or enable cooperative binding. For example, TCR
clustering and cooperativity between TCRs in the cluster may give
rise to a high“apparent”on-rate for TCR:pMHC association. Mul-
tivalent interactionmay result in ahigh“apparent”binding afﬁnity.
Cellular responses such as those that involve active participation of
the cytoskeleton have been proposed to generate a high“apparent”
off-rate (Huppa et al., 2010; Robert et al., 2012). While these pos-
sibilities seem reasonable, these hypothetical mechanisms require
additional studies to elucidate. Without knowing the quantitative
contributions of these effects, it is difﬁcult to relate the 3Dparame-
ters or even 2D parameters measured using puriﬁed recombinant
TCR constructs (Robert et al., 2012) to 2D parameters measured
with cell surface TCRs.
The relative importance of keeping the TCR or pMHC on the
cell surface to the kinetic measurements is revealed by two sets
of tetramer staining experiments (Adams et al., 2011). Tetramers
consisting of 42F3 TCRs stained peptide p3A1 loaded APCs, but
p3A1:H2-Ld pMHC tetramers did not stain 42F3 T cells, demon-
strating that the outcome of the interaction of this receptor:ligand
pair strongly depends on how molecules are displayed. Interest-
ingly, in spite of a substantial difference between SPR and 2D data,
a strong correlation was observed between SPR 3D afﬁnities and
42F3 TCR tetramer staining of a panel of peptide loaded APCs.
However, the pMHC tetramers binding to intact T cell receptors
on 42F3 T cells correlated with the 2D, not 3D, afﬁnities (Adams
et al., 2011).
CD8 CORECEPTOR ENHANCES PEPTIDE DISCRIMINATION BY
TCR
TCR:pMHC interaction is enhanced by the coreceptors (CD8
or CD4) presented on T cell surface, which bind MHC class
I or II molecules, respectively. The exact mechanism of core-
ceptor action is still unknown, although characteristics of
TCR:pMHC:coreceptor interaction were reported and several
models were proposed (Janeway, 1992; Xu and Littman, 1993).
A recently published study using the micropipette adhesion fre-
quency assay showed that adhesion between OT1 T cells and
pMHC loaded RBCs strengthens due to CD8 coreceptor involve-
ment/cooperation, and this effect is signaling dependent (Jiang
et al., 2011). 2D measurements showed that the afﬁnity of the
class I MHC:CD8 interaction is several orders of magnitude lower
than the afﬁnity for TCR interacting with agonist pMHC (Huang
et al., 2007), suggesting that only a synergistic effect or cooper-
ation between TCR and CD8 results in the signiﬁcant adhesion
upregulation effect. Figure 1D shows the comparison of normal-
ized adhesion bonds (average number of bonds per unit pMHC
density) versus 3D afﬁnity for three different types of interaction:
pMHC:CD8 (blue circles), TCR:pMHC (red circles) and trimol-
ecular interaction TCR:pMHC:CD8 (black circles) for the OT1
T cell system and for a panel of different peptides. pMHC:CD8
interaction alone has signiﬁcantly lower afﬁnity than TCR bind-
ing to agonist pMHC both in 2D and 3D (Figure 1D). Still, it is
apparent that when CD8 is allowed to bind agonist pMHC the
normalized adhesion bonds increased signiﬁcantly (Figure 1D).
The same 3D afﬁnity is used for each peptide (labeled above
the arrows) to present 2D data for TCR:pMHC and trimolecular
TCR:pMHC:CD8 interaction results. CD8-dependent upregula-
tion occurs after initial signaling through Lck and increases overall
sensitivity to antigen (Jiang et al., 2011).
Previously, it has been suggested that the minimal ligand
required to induce TCR triggering is a pMHC dimer (Boniface
et al., 1998; Cochran et al., 2001). Two sets of results from recently
published 2D kinetics argue against this. In the micropipette adhe-
sion frequency assay biotinylatedpMHCmonomerswere captured
by streptavidin coated on biotinylated RBCs. Wild-type, tetrava-
lent streptavidin allows pMHC dimer formation, whereas divalent
streptavidin allows only pMHC monomer. Use of divalent strep-
tavidin resulted in TCR:pMHC interaction similar to unmodiﬁed
streptavidin for the same total density of captured pMHCs (Huang
et al., 2010). Another argument against a necessity of dimer to ini-
tiate signaling is that lowering the pMHCs density to the level
predicted to allow only single molecule interaction (Chesla et al.,
1998) still generated the CD8-dependent adhesion upregulation
that was shown to require early signaling events (Jiang et al., 2011).
Several lines of investigation have suggested that CD8 may
inﬂuence both the on- and off-rate of the TCR:pMHC class
I interaction (Gakamsky et al., 2005; Wooldridge et al., 2005;
Laugel et al., 2007; van den Berg et al., 2007), and suggested
that the extent of CD8 coreceptor dependence is inversely cor-
related to TCR:pMHC class I afﬁnity (Laugel et al., 2007). One
of the unexpected results that emerged from 2D kinetic studies
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is that TCR–CD8 cooperation ampliﬁes peptide discrimination.
TCR showed signiﬁcantly higher afﬁnity for agonist pMHC at
baseline and CD8 coreceptor additionally strengthened the inter-
action with agonist more than lower potency peptides (Jiang et al.,
2011). This is shown in Figure 1D where the y-axis uses a log scale
to accommodate results of both strong and weak ligands. Note
that in the log scale small differences in weak ligands of low afﬁni-
ties are stretched while large differences in strong ligands of high
afﬁnities are compressed.
Figure 2 shows a schematic representation illustrating the
assembly of trimolecular TCR:pMHC:CD8 complex. Figure 2A
shows a resting state with no interaction. Figure 2C (bottom left)
showsCD8 interactionwithMHCbearing self-peptide (open sym-
bol peptide while agonist peptide in panels Figures 2A,B,D is in
closed symbol). This is aweak interaction (Figure 1D) that dynam-
ically occurs in resting T cells, as most of the MHC molecules
are loaded with self-peptides. It was shown that 2D pMHC:CD8
resting interaction could be perturbed by disrupting the mem-
brane rafts (Huang et al., 2007). Resting interaction between CD8
and pMHC by itself will not lead to a signaling event. Panel B
(top right) depicts TCR:pMHC binding as the ﬁrst step that will
initiate signaling and tyrosine phosphorylation of the TCR–CD3
ITAMs by Lck not associated with coreceptor, which was proposed
previously in a coreceptor recruitment model (Xu and Littman,
1993; van der Merwe and Cordoba, 2011). It was shown that the
agonist TCR:pMHC interaction at this step could be affected by
drugs perturbing the actin cytoskeleton and disrupting the mem-
brane rafts (Huang et al., 2010). ITAM phosphorylation leads to
recruitment of CD8 coreceptor through the SH2 domain of Lck
associated with its cytoplasmic tail. Figure 2D depicts one pro-
posed mechanism whereby coreceptor association with TCR–CD3
occurs through the binding of the Lck SH2 domain to a pTyr
residue on Zap-70(Thome et al., 1995).
COMPARISONS BETWEEN 2D MEASUREMENTS AND
PEPTIDE:MHC TETRAMER BINDING
Peptide:MHC multimers have been used for the last 15 years as a
means of detecting antigen speciﬁc T cells (Altman et al., 1996).
More recently, tetramers have been used clinically to monitor
patient responses to vaccines (Lee et al., 1999; Blattman et al., 2003;
Danke andKwok,2003;Mancini-Bourgine et al., 2004; Firbas et al.,
2006). Several studies have attempted to verify that tetramers iden-
tify all antigen speciﬁc T cells. Studies by Day et al. (2003), Scriba
et al. (2005) showed that tetramer staining frequencies correlated
roughly with the frequency of IFN-γ producing cells by intra-
cellular cytokine staining using HCV- and HIV-speciﬁc cell lines
respectively. Basedon these data, it has been generally accepted that
tetramer staining effectively identiﬁes all of the antigen speciﬁc T
cells.
In contrast to these studies suggesting tetramer staining pro-
vides complete coverage of the polyclonal T cell response, a study
by Hernández et al. (2000) demonstrated that a population of
CD8+ T cells were antigen speciﬁc as determined by lytic activity
but failed to stain with tetramer. This was one of the ﬁrst studies
to show that tetramer staining may not identify all antigen speciﬁc
T cells. Similarly, a second study showed that a cell line speciﬁc for
a ubiquitous tumor antigen was able to make IFN-γ by ELISpot
in response to peptide, but this cell line did not stain with the
tetramer loaded with the same peptide (Laugel et al., 2007). Both
of these studies through indirect analysis showed that tetramer
staining was not capable of identifying all of the antigen speciﬁc
cells. Although the authors did not comment on the data, a study
by Pittet et al. (2001a,b) showed that in response to cognate anti-
gen, there were tetramer negative cells that were making IFN-γ as
detected using a cytokine capture assay to measure the release of
cytokines, thereby allowing costaining with tetramer.
To further clarify this issue, the 2D micropipette adhesion fre-
quency assay has been used to detect polyclonal T cells speciﬁc
for either a self or foreign antigen, as this assay has a broader
range of detection than traditional tetramer staining (Sabatino
et al., 2011). Direct ex vivo analysis of puriﬁed CD4+ T cells
from the central nervous system of mice at the peak of exper-
imental autoimmune encephalomyelitis (EAE) revealed that the
2D binding assay detected approximately eight times more MOG
antigen speciﬁc cells than the tetramer (∼63 vs.∼8%). For gp61–
80, an epitope from lymphocytic choriomeningitis virus, at the
peak the T cell response (day 8 post-infection) there were approx-
imately four times more cells detected by the 2D binding assay
as compared to tetramer staining (∼33 vs. ∼9%). Furthermore,
by sorting CD4+ CD44+ tetramer negative cells and compar-
ing them with total CD4+ CD44+ cells in their ability to pro-
duce cytokine in response to antigen, we found that the sorted
tetramer negative population accounted for approximately half of
the amount of IFN-γ and TNF-α produced by the entire popu-
lation, emphasizing that even highly functional antigen speciﬁc
T cells do not always stain with tetramer reagents. These data
clearly show that tetramer does greatly underestimate the number
of antigen speciﬁc cells, the tetramer negative cells are capa-
ble of producing cytokines and that tetramer staining requires
a minimum afﬁnity of the TCR for the pMHC (summarized in
Table 2).
Table 2 | Comparison between 2D and tetramer identification of
antigen specific cells.
2D Tetramer Reference
Detection of a
self antigen in
polyclonal
response
63% 8% Sabatino et al.
(2011)
Detection of a
viral antigen in
polyclonal
response
33% 9% Sabatino et al.
(2011)
Correlation
with functional
data
Detects more
antigen
speciﬁc than
by cytokine
production
alone&
Can miss
antigen
speciﬁc cells
as determined
by speciﬁc
lysis
†
, and
cytokine
production*, ∧, &
†Hernández
et al. (2000),
*Laugel et al.
(2007), ∧Pittet
et al. (2001a),
&Sabatino
et al. (2011)
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As discussed above, an engineered pMHC which had the high-
est 3D afﬁnity measured by SPR for all of the engineered pMHCs
tested, when tetramerized, was not able to stain either 42F3 TCR
transgenic cells or hybridomas expressing the speciﬁcTCR (Adams
et al., 2011). Even though this tetramer did not stain cells, the 2D
afﬁnity for this TCR:pMHC interaction was detectable. Additional
studies have shown that there are many inherent problems with
tetramers (Stone et al., 2011). For example, using streptavidin to
oligomerize pMHC monomers the majority of the oligomers con-
sisted of trimers, although tetramerswere also present (Stone et al.,
2011). Detection of antigen speciﬁc cells through the use of pMHC
multimers is thought to be effective due to the increased avidity
of having multiple binding sites, thus compensating for the fast
dissociation rates. It is likely that not all of the binding sites are
able to bind TCRs simultaneously due to steric hindrance, perhaps
making trimers even less sensitive than tetramers or higher order
oligomers. Additionally, even at extremely high concentrations of
tetramer, only 10–30% of the TCRs on the cells were engaged with
tetramer. Using a range of peptides capable of being recognized by
the same TCR but having a spectrum of 3D afﬁnities, Stone et al.
demonstrated that for lower afﬁnity interactions tetramer staining
was extremely low, and that 80–90% of the tetramer that was able
to bind could dissociate during a normal wash step to prepare the
cells for analysis by ﬂow cytometry.
Based on all of these reports, caution should be exercised in
the interpretation of tetramer staining, especially for interactions
likely to be lower afﬁnity, such as self peptides and tumor antigens,
but also for higher afﬁnity populations such as those found in viral
infection. Using techniques that can track tetramer staining and
cytokine production simultaneously, whether by cytokine capture
assays or the use of cytokine reporter mice, will help to highlight
the contribution of lower afﬁnity cells to an immune response.
STUDYING T CELL ACTIVATION USING 2D MEASUREMENTS
IS KEY
The unique context of the T cell plasma membrane, including
lipid rafts, association with other receptor components including
CD3 and coreceptor, clusters of TCRs, and the overall structural
arrangement of all of these components play a role in regulating
the T cell response to antigen. Studies utilizing 3D methods can
provide important information regarding the interaction dynam-
ics of a single receptor ligand pair or even a pool of TCRs derived
from a polyclonal population. However, the removal of these pro-
teins from their native context clearly alters the ways in which they
interact. To circumvent this weakness, 2D approaches utilize pro-
teins anchored in a membrane context. Thus far, these studies have
utilized intact T cells binding to pMHC ligands on surrogate anti-
gen presenting cells (either planar membranes or coupled to RBCs
or beads; Huang et al., 2010; Huppa et al., 2010). The approach
of using intact T cells provides a number of advantages, includ-
ing the ability to utilize knockout or transgenic cells, assessment
of the role of signaling events, visualization of calcium ﬂux and
other aspects of early T cell activation.
Thus far, 2D studies have utilized CD8 negative hybridomas,
antibody blockade or mutant MHC molecules that do not bind
CD8 to eliminate the contribution of the CD8 coreceptor to the
TCR:pMHC interaction (Huang et al., 2007, 2010; Adams et al.,
2011; Jiang et al., 2011). Similarly, genetic knockout T cells or cells
in which siRNA has been employed to alter the expression of a
protein of interest will allow for the assessment of the role indi-
vidual components play in the adhesion of the T cell to an antigen
presenting cell, as well as perhaps determining which components
are required for the initiation of signaling events. In addition to
knockout T cells, transgenic reporter T cells can also be used in 2D
assays, thus allowing direct comparison of differences in binding
parameters between various sub-populations of cells.
Furthermore, pharmacologic inhibitors can be utilized to eluci-
date the role of various signaling events in controlling TCR:pMHC
adhesion, as we have previously demonstrated with the Src family
kinase inhibitor PP2 (Jiang et al., 2011). Beyond the somewhat
non-speciﬁc approach of using inhibitors, 2D assays also allow
for the detection of calcium ﬂux following TCR interaction with
pMHC, thus providing a unique means of assessing the precise
requirements for this early T cell activation event. In addition
to calcium signaling, the development of FRET-based sensors
may allow assessment of recruitment of signaling components
to the TCR complex and potentially the detection of phosphory-
lation events. These or other ﬂuorescence based approaches may
ultimately provide a means to study each distinct signaling step
of T cell activation and how the binding kinetics and various
components of the TCR complex contribute to this process.
CONCLUDING REMARKS
Measurements of TCR:pMHC interactions by both SPR and
tetramer analysis have yielded a great deal of useful information
regarding how T cells may achieve activation. SPR measurements
only provide data as to the pure chemical binding between the
engineered proteins, while pMHC tetramers are unable to identify
all antigen reactive T cells in most cases. Each of these methods
lacks the context of the cell membrane in which both the TCR and
pMHC are anchored during in vivo T cell activation. Assessment
of the interaction dynamics of puriﬁed proteins has been largely
unable to predict the functional outcome of TCR:pMHC interac-
tion. Correlation between functional outcomes and 3D interaction
kinetics are often poor, and at best, only some parameters correlate
with T cell function. However, as we and Davis and colleagues have
demonstrated for both CD8+ and CD4+ T cells respectively, all
2D parameters correlate well with effector function (Huang et al.,
2010; Huppa et al., 2010).
The use of 2D approaches to study TCR:pMHC interactions, as
well as other receptor:ligand interactions, will continue to expand
our knowledge of how characteristic kinetic phenotypes are trans-
lated into downstream signaling programs. Furthermore, compar-
ison of 2D, 3D, and structural data will provide novel insights into
the membrane dynamics and signaling requirements that regulate
T cell responses.
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